相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles
Jaime A. Castro-Mondragon et al.
NUCLEIC ACIDS RESEARCH (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
Shuang Cui et al.
CELL DEATH & DISEASE (2021)
RNA Helicases as Shadow Modulators of Cell Cycle Progression
Olga Sergeeva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense
Frances Taschuk et al.
VIRUSES-BASEL (2020)
Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing
Kailong Li et al.
NATURE COMMUNICATIONS (2020)
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
Samrat Roy Choudhury et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration
Yanni Xu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC
Yalei Yin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
Xindong Liu et al.
NATURE (2019)
Molecular mechanism of the RNA helicase DHX37 and its activation by UTP14A in ribosome biogenesis
Franziska M. Boneberg et al.
RNA (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial
Douglas Adkins et al.
LANCET ONCOLOGY (2019)
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Matthew B. Dong et al.
CELL (2019)
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhao Zhang et al.
NATURE COMMUNICATIONS (2019)
The human RNA helicase DHX37 is required for release of the U3 snoRNP from pre-ribosomal particles
Priyanka Choudhury et al.
RNA BIOLOGY (2019)
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
Arian Lundberg et al.
BREAST CANCER RESEARCH (2019)
Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model
Xuguang Zhu et al.
CLINICAL CANCER RESEARCH (2017)
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Wanpei Cai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells
Masmudur M. Rahman et al.
SCIENTIFIC REPORTS (2017)
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Wanpei Cai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger et al.
CLINICAL CANCER RESEARCH (2017)
The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
P. L. Garcia et al.
ONCOGENE (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
Ruben Niesvizky et al.
LEUKEMIA & LYMPHOMA (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways
Samaan Samaan et al.
NUCLEIC ACIDS RESEARCH (2014)
OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
Lu Cao et al.
BMC CANCER (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D. Buenrostro et al.
NATURE METHODS (2013)
DEAD box RNA helicase functions in cancer
Frances V. Fuller-Pace
RNA BIOLOGY (2013)
Perturbations of RNA helicases in cancer
Francis Robert et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2013)
ChIP-seq: Using high-throughput sequencing to discover protein-DNA interactions
Dominic Schmidt et al.
METHODS (2009)
DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes
K. Tanaka et al.
ONCOGENE (2009)
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer
Jerome Eeckhoute et al.
GENES & DEVELOPMENT (2006)
The activities of cyclin D1 that drive tumorigenesis
ME Ewen et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Dead-box proteins: The driving forces behind RNA metabolism
S Rocak et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
分享论文
